Background/Aims: Neuroinflammation mediated by activated microglia may play a pivotal role in a variety of central nervous system (CNS) pathologic conditions, including ethanolinduced neurotoxicity. The purpose of this study was to investigate the function of Tβ4 in ethanol-induced microglia activation. Methods: Quantitative real-time PCR was conducted to assess the expression of Tβ4 and miR-339-5p. Western blot analysis was used to measure the expression of Tβ4, phosphorylated p38, ERK, JNK, Akt, and NF-κB p65. The concentration of TNF-α and IL-1β was determined using ELISA. NO concentration was measured using a nitric oxide colorimetric BioAssay Kit. Double immunofluorescence was performed to determine Tβ4 expression, in order to assess microglial activation in neonatal mouse FASD model. Results: Increased Tβ4 expression was observed in ethanol treated microglia. Knockdown of Tβ4 enhanced ethanol-induced inflammatory mediators tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) and nitric oxide (NO) in BV-2 cells was performed. Exogenous Tβ4 treatment significantly inhibited expression and secretion of these inflammatory mediators. Tβ4 treatment attenuated p38, ERK MAPKs, and nuclear factor-kappa B (NF-κB) pathway activation, and enhanced miR-339-5p expression induced by ethanol exposure in microglia. A neonatal mouse fetal alcohol spectrum disorders (FASD) model showed that Tβ4 expression in the microglia of the hippocampus was markedly enhanced, while Tβ4 treatment effectively blocked the ethanol-induced increase in inflammatory mediators, to the level expressed in vehicle-treated control animals. Conclusion: This study is the first to demonstrate the function of Tβ4 in ethanol-induced microglia activation, thus contributing to a more robust understanding of the role of Tβ4 treatment in CNS disease.
Introduction
Prenatal exposure to ethanol can damage the developing fetus and is the leading preventable cause of birth defects and intellectual and neurodevelopmental disabilities. Fetal alcohol spectrum disorder (FASD) resulting from fetal exposure to ethanolic the general term that encompasses the range of adverse effects associated with prenatal ethanol exposure, and is the leading cause of mental retardation in the United States [1] . There is currently no effective treatment that targets the causes of these disorders. Thus, novel therapies are critically needed to limit the neurodevelopmental and neurodegenerative pathologies associated with FASD. Both clinical and preclinical evidence suggest that microglia, the immune cells of the central nervous system (CNS), play a key role in modulating ethanol-induced neurotoxicity. In particular, microglia is implicated in ethanol-induced neuroinflammation and in ethanolinduced increases in oxidative stress, which can lead to neuronal apoptosis [2] . Therefore, safe and effective interventions, including those that target microglia activation, are urgently required to minimize ethanol-induced neurologic deficits.
Thymosin beta4 (Tβ4), a 43-amino acid pleiotropic actin-sequestering polypeptide, was first isolated from calf thymus tissue and subsequently found in all mammalian species [3] . Tβ4 is the major G-actin-sequestering molecule with diverse functions related to cell proliferation, migration, angiogenesis, cell survival, and inhibition of inflammation [4] [5] [6] [7] . Multiple studies have indicated that Tβ4 protein may promote tissue regeneration in multiple processes including corneal, epidermal, and cardiac wound healing, and is also effective in inflammatory diseases including severe acute pancreatitis and bleomycininduced lung fibrosis [8] . In CNS, Tβ4 has been reported to be neuroprotective in rodents with experimental autoimmune encephalomyelitis, stroke and traumatic brain injury (TBI), and also neonatal rats following hypoxia brain injury [9] [10] [11] [12] . The effects of Tβ4 in these diseases are partly through inhibition of inflammation. The microglia are the most important inflammatory cells in the CNS; inflammation mediated by activated microglia leads to pathologic changes in most CNS diseases and injury [13] [14] [15] . Endogenous Tβ4 in the CNS is reported to be expressed mainly in microglia and direct evidence has shown that Tβ4 may inhibit inflammatory factor expression in microglia after hypoxia [12] . Furthermore, systemic administration of Tβ4 is safe and well-tolerated by humans and animals, including neonatal rats [3] .
Herein, we investigated the expression and role of Tβ4 in ethanol-induced microglia activation and also observed the effect of Tβ4 treatment on microglia-mediated inflammation both in vitro and in an in vivo neonatal mouse FASD model.
Materials and Methods

Neonatal mouse FASD model and Tβ4 treatment
All animal procedures were performed according to protocols approved by the Animal Care and Use Committee of Fudan University (Shanghai, China). Neonatal C57BL/6 mice (female) were randomly divided into three groups: (1) normal mice (n = 7); (2) ethanol treated mice (n = 8); and (3) ethanol +Tβ4 (6 mg/ kg) [16] group (n = 8). We used a synthetic copy of the naturally-occurring 43-amino acid Tβ4 peptide (RegeneRx, Bethesda, MD, USA). The animal experiment was performed as described previously [17, 18] . In brief, 4 g/kg/d ethanol or control was administered daily by intraesophageal gavage on postnatal days 4 through 9. Tβ4 or control (water) was given 1 h before ethanol treatment. Tissues were collected 1 day after the final ethanol treatment for further analysis.
Silencing of Tβ4 with small interfering RNA (siRNA) Tβ4 was silenced using Tβ4 siRNA (GeneChem, Shanghai, China) according to the manufacturer's instructions. BV-2 cells transfected with nonspecific scramble siRNA that does not target any mouse genes (control siRNA) were used as controls. Transfected cells were subjected to ethanol in free DMEM for 8 h. Then, protein was extracted for western blotting or supernatants were used for ELISA analysis as described below.
Double immunofluorescence
Animals were anesthetized with isoflurane and perfused transcardially with a brief heparinized PBS flush followed by phosphate-buffered (PB) 4% paraformaldehyde fixative [18] . Double immunofluorescence was performed as previously described [12] . Coronal sections of brain were stained with Iba-1 and Tβ4 antibodies (Abcam, Cambridge, UK). In brief, Iba-1 and Tβ4 primary antibodies were incubated overnight at 4°C and then stained with FITC and TRITC conjugated secondary antibodies. Nuclei were counterstained by 4′, 6-diamidino-2-phenylindole (DAPI). Images were visualized using confocal fluorescence microscopy (Leica DM5500 B).
Western blot analysis
Total protein was extracted and quantified using a BCA Protein Assay Kit (Pierce Biotechnology Inc., Rockford, IL, USA). Equal amounts of protein were separated by SDS-PAGE (15% for Tβ4 detection), then transferred onto nitrocellulose filter membranes (Bio-Rad, Hercules, CA, USA) and blocked with 5% nonfat milk. The following antibodies were used: anti-Tβ4 (1:1000, Santa Cruz Biotechnology), anti-NF-κB p65 (1:1000, Santa Cruz Biotechnology), anti-p-ERK (1:2000, Cell signaling technologies), anti-ERK (1:2000, Cell signaling technologies), anti-p-p38 (1:500, Cell signaling technologies), anti-p38 (1:1000, Cell signaling technologies), anti-p-JNK (1:1500, Cell signaling technologies), anti-JNK(1:1000, Cell signaling technologies). Horseradish peroxidase-conjugated were used as secondary antibodies. Target proteins were detected according to standard methods and β-actin was used as an internal control.
RNA extraction and quantitative real time-PCR (qRT-PCR)
RNA was extracted using the RNeasy Mini kit (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions. RNAs were mixed with oligo (dT) or miRNA specific stem-loop RT primers and reverse transcribed to cDNA using a First Strand cDNA Synthesis Kit (Fermentas, Burlington, Canada). qRT-PCR was performed using SYBR Premix Ex Taq (TaKaRa, Dalian, China) and measured in a Light Cycler 480 system (Roche, Basel, Switzerland).The expression differences for genes between different groups were calculated by normalizing with the β-actin or U6 expression according to the 2 -ΔΔCT method.
Cytokines and nitrite concentration measurements
To determine the levels of TNF-α and IL-1β secreted from brain tissue and the culture medium from BV-2 cells, supernatant collected from treated and untreated microglia were analyzed using a TNF-α/ IL-1β ELISA kit (R&D Systems, Minneapolis, MN, USA), according to the manufacturer's instructions. NO concentration was measured using a nitric oxide colorimetric BioAssay Kit (US Biologicals; Salem, MA, USA), according to the manufacturer's instructions.
Statistical analyses
Comparison of data was performed in cell cultures with and without Tβ4. Data is presented as the mean ± standard deviation. The differences between groups were analyzed using Student's t-test when comparing only two groups or assessed by one-way analysis of variance when more than two groups were compared. A p-value of less than 0.05 was considered statistically significant. All experiments were performed in triplicates.
Results
Tβ4 expression was increased in ethanol treated microglia
Endogenous Tβ4 has been reported to be expressed by microglia. However, whether and how Tβ4 is expressed in an ethanol-induced microglial cell line has not been investigated.
To explore this, Tβ4 expression was detected in the BV-2 microglial cell line after ethanol treatment using qRT-PCR. Tβ4 mRNA expression was significantly elevated after ethanol treatment for 15 min, 30 min, and 1 h, respectively, and most conspicuous after 30 mins (Fig. 1A) . Tβ4 protein expression increased significantly after ethanol treatment for 1 h by western blot analysis (Fig. 1B) .
Effects of Tβ4 treatment on secretion of inflammatory mediators in ethanol treated microglia
The effects of Tβ4 on the diseases previously described are partly through inhibition of inflammation. Microglia are the most important inflammatory cells in the CNS. In order to identify whether Tβ4 has an anti-inflammatory effect in ethanol-exposed BV-2 cells, the concentration of TNF-α and IL-1β were determined in ethanol-exposed BV-2 cells treated with Tβ4, using ELISA. TNF-α and IL-1β protein secretion was suppressed in ethanol exposed BV-2 cells treated with Tβ4 compared with those that did not receive Tβ4 ( Fig. 2A-B) . The most striking change was observed in NO concentration, which was significantly decreased in ethanol exposed BV-2 cells treated with Tβ4, compared with those without Tβ4 treatment (Fig. 2C) . To further verify the anti-inflammatory effect of Tβ4, Tβ4 was silenced with siRNA in BV-2 cells to investigate the release of inflammatory mediators. ELISA demonstrated that TNF-α and IL-1β secretion was also enhanced considerably in ethanol exposed BV-2 cells with Tβ4 silenced (Fig. 2D-E) . A similar change was observed in NO concentration, which was significantly increased in Tβ4 silenced treated groups (Fig. 2F) .
P38, ERK MAPKs, and NF-κB pathways were involved in ethanol induced microglial activation treated with Tβ4
Tβ4 was added to the BV-2 cells to observe the activation of cell signaling pathways involved in microglial activation after ethanol exposure. Western blot analysis demonstrated that expression of phosphorylated p38, ERK, JNK, Akt, and NF-κB p65 was increased after ethanol exposure. The increase of p-p38, p-ERK, p-JNK, and NF-κB p65 was attenuated by Tβ4 treatment while no significant change was observed in p-Akt expression (Fig. 3) .
miR-339-5p expression was increased in ethanol induced activated microglia treated with Tβ4
Given that miRNAs are involved in microglial inflammatory responses, we detected the expression of miR-339-5p, miR-124, miR-367, and miR-9 during ethanol exposure as well as in Tβ4-treated BV-2 cells, which have been reported to be associated with microglial activation [20] [21] [22] [23] . No significant change in miR-124, miR-367, and miR-9 expression were observed in BV-2 cells after ethanol exposure or Tβ4 treatment. However, miR-339-5p expression was enhanced in ethanol exposed BV-2 cells compared with normal control BV-2 cells. Expression of miR-339-5p revealed a significant increase in Tβ4-treated ethanol exposed BV-2 cells compared with those without Tβ4 treatment (Fig. 4) .
Endogenous Tβ4 expression in microglia was increased in neonatal mouse brain with FASD
Endogenous Tβ4 has been reported to be expressed in mouse microglia. Immunohistochemical staining with Iba-1 in the hippocampus was performed to determine Tβ4 expression, in order to assess microglial activation. Most Tβ4 expression cells are Iba-1 positive in different groups. The intensity of Tβ4 immunoexpression was lower in the control microglia mice and highly enhanced 1 d after ethanol exposure (Fig. 5) .
Tβ4 attenuated the release of inflammatory mediators and blocked ethanol-induced morphologic change of microglia in neonatal mice with FASD
Most important inflammatory mediators, including TNF-α, IL-1β, and NO, contribute to neuroinflammation in CNS disease. We investigated the effect of Tβ4 treatment in neonatal mice with FASD on production of TNF-α, IL-1β, and NO in the hippocampus. Secreted TNF-α and IL-1β were quantified by ELISA and NO concentration was assessed in the cell culture media. Both TNF-α and IL-1β concentration were enhanced 1 d after ethanol exposure in mice and were significantly inhibited in Tβ4 treated groups (Fig. 6A-B) . The release of NO in mice treated with ethanol was markedly increased and suppressed in Tβ4 treated mice (Fig. 6C ).
Discussion
It is well established that maternal consumption of alcohol during pregnancy will lead to FASD with deficits in CNS development [24, 25] . Despite the knowledge that has been gained in this alcohol-induced neuro disorder, there are no effective treatments that target the neuropathologic causes of FASD. We investigated the role of Tβ4 in neuroimmune cell microglia in FASD neuropathology, uncovering a potential role for Tβ4 in suppressing microglia activation and neuroinflammatory events after alcohol stimulation. The antiinflammatory therapeutic approach by exogenous Tβ4 treatment may be effective throughout an extended time frame in infants with FASD.
Recently, it has become clear that chronic alcohol abuse results in immune activation in the CNS of neonatal to aged animals, and is believed to contribute to neurodegeneration [26] [27] [28] . In the developing brain, ethanol causes death of Purkinje neurons and cerebellar granule cell neurons of mice in vivo and in vitro [29, 30] . Importantly, microglia that survives the toxic effects of ethanol had the phenotype of activated pro-inflammatory and phagocytic cells in the cingulated cortex of an FASD model [14] . In this study, we also found that neonatal mice with alcohol exposure-induced microglia activation, confirming the role of microglia activation in ethanol-induced brain injury in the developing brain.
Tβ4, the major G-actin-sequestering molecule in eukaryotic cells, has shown properties including anti-inflammation [9] . Tβ4 has been shown to be effective in the treatment of a variety of neurologic injuries and degenerative diseases. We demonstrated an antiinflammatory effect of Tβ4 in alcohol induced microglial activation both in vitro and in neonatal mice with FASD in vivo. We confirmed an increase in Tβ4 expression in the activated microglia of neonatal mice and also in BV-2 microglia after alcohol exposure. Tβ4 silencing enhanced the inflammatory factors released in BV-2 cells; exogenous Tβ4 inhibited the release of inflammatory factors in BV-2 cells. Furthermore, Tβ4 treatment hindered the inflammatory process in the hippocampus of neonatal mice after alcohol exposure. It is worth noting that an increase in the endogenous expression of Tβ4 in the BV-2 microglial cell lines treated with alcohol and in the FASD model was observed, suggesting a protective effect of Tβ4 on microglia with ethanol injury. However, the mechanism of Tβ4 increase in alcohol-induced activated microglia requires further study.
Cell signaling pathways including MAPK, NF-κB, and Akt pathways have been reported to be involved in microglial activation. We found that MAPK, NF-κB, and Akt pathway activation was increased in ethanol-induced microglia activation. Importantly, p38, ERK, and JNK MAPK pathways, as well as NF-κB pathways are involved in Tβ4 treated microglia. The regulation of Tβ4 in the activation of MAPK and NF-κB pathways has been reported in human periodontal ligament cells [7] , which was consistent with our observation in microglia cells after ethanol exposure.
MicroRNAs, small 22-25 nucleotide noncoding RNAs, have the ability to affect the translation of many proteins and are involved in mediating microglia activation [31] . Consistent with previous observations, miRNA-339-5p was found to be upregulated in mouse alcohol-induced brain damage [32] . We found that ethanol itself could induce miR-339-5p expression; meanwhile, Tβ4 treatment could induce a significant increase in miR-339-5p expression in BV2 cells exposed to ethanol. However, the underlying molecular mechanism requires further clarification.
Importantly, the safety of Tβ4 has been demonstrated in human trials, which support the substantial potential for clinical translation in the treatment of neurologic disorders [8] . Our findings may further elucidate the potential role and molecular mechanisms of Tβ4 and provide promising therapies for neurologic and other CNS diseases, especially in the developing brain. Zhang et 
